Competitor Analysis Guide
Competitor Analysis Guide

Know what you're actually up against.

A structured, repeatable teardown of your three closest competitors — what they're genuinely good at, what they claim, and where that leaves room for you to specialize rather than compete head-on.

Fair warning: done honestly, this exercise is meant to be a little humbling.

How to use this guide

Run the same teardown three times

Pick your three closest competitors — the ones a buyer would actually compare you to, not the ones you wish you were competing with. Run the identical six-section teardown on each, then use the closing synthesis to find your wedge.

1

Research before you reflect

Sections A–C are fact-finding: annual reports, FDA/CE databases, published trials, their own website and sales collateral. Get the facts down before you interpret them.

2

Separate what's real from what's claimed

Section C is their marketing voice. Section D is where you go looking for the gap between what they say and what the evidence actually shows.

3

Don't do Section E alone

The gut-check questions are designed to surface uncomfortable answers. Do this section with a cofounder, advisor, or someone outside the building — it's too easy to talk yourself out of the hard answers solo.

4

Write down where they're better — don't rationalize it away

The instinct will be to minimize a competitor's strengths. Resist it. An honest list of where you lose today is what makes the synthesis at the end actually useful.

COMPETITOR 01
Section A — The Facts

Snapshot data — pull this from public filings, FDA/CE databases, their site, LinkedIn, and press coverage.

Founded / HQ
Funding raised or parent company
Estimated revenue or market share
Install base / number of customers
Regulatory status (FDA clearance, CE mark, class, date)
Key leadership or scientific advisory board
Section B — What They're Actually Good At

Set marketing language aside for now — this is your honest technical and commercial read of their real strengths.

Core technical or clinical strength
What do they genuinely do better than most of the category — not what they say, what's actually true?
Clinical evidence strength
What published trials, studies, or real-world data actually back their product?
Distribution & channel strength
Sales force size, GPO contracts, distributor relationships, existing hospital footprint.
Brand & relationship equity
Key opinion leaders, society endorsements, conference presence, word-of-mouth trust.
Section C — What They Claim (Marketing & Clinical)

This is their voice, not yours — pull language straight from their website, sales decks, and published claims.

Primary marketing message / tagline
The one line they lead with in a pitch or on their homepage.
Top 3 clinical or performance claims
The specific claims they make publicly — numbers, comparisons, outcomes.
Where these claims are published
Peer-reviewed journal, white paper, conference poster, or sales collateral only? The venue tells you how rigorously the claim was tested.
Section D — Where Claims Might Outrun the Reality

Go looking for the gap. Forums, app store reviews, conference hallway conversations, peer-reviewed rebuttals, FDA MAUDE reports, and user complaints all live here.

What would a skeptical clinician ask?
If you handed their claims to a sharp, unaligned clinician, what's the first question they'd push back with?
Documented complaints or limitations
What shows up in reviews, forums, MAUDE/adverse-event databases, or published critiques?
Recalls, retractions, or public incidents
Anything on the regulatory or public record worth knowing about.
Section E — The Uncomfortable Questions

Answer these with someone outside the building. Resist the instinct to talk yourself out of the hard answers.

If a hospital's current process works “well enough” with this competitor, why would they tear it out for us?

What do they have — capital, relationships, data, regulatory history, install base — that we cannot realistically replicate in the next 24 months?

If we only match them feature-for-feature, why would anyone actually switch?

What is the one thing this competitor cannot or will not do — because of their size, business model, or incentives — that we could?

Where are they clearly, honestly better than us today? Write it down. Don't rationalize it away.

Section F — Implication for Our Specialization

Given everything above, what narrow wedge or use case could we own that this competitor is structurally unlikely to defend?

Our specialization opportunity against this competitor
Be specific: a use case, a patient population, a workflow moment, a buyer type — not “we'll be more innovative.”
COMPETITOR 02
Section A — The Facts

Snapshot data — pull this from public filings, FDA/CE databases, their site, LinkedIn, and press coverage.

Founded / HQ
Funding raised or parent company
Estimated revenue or market share
Install base / number of customers
Regulatory status (FDA clearance, CE mark, class, date)
Key leadership or scientific advisory board
Section B — What They're Actually Good At

Set marketing language aside for now — this is your honest technical and commercial read of their real strengths.

Core technical or clinical strength
What do they genuinely do better than most of the category — not what they say, what's actually true?
Clinical evidence strength
What published trials, studies, or real-world data actually back their product?
Distribution & channel strength
Sales force size, GPO contracts, distributor relationships, existing hospital footprint.
Brand & relationship equity
Key opinion leaders, society endorsements, conference presence, word-of-mouth trust.
Section C — What They Claim (Marketing & Clinical)

This is their voice, not yours — pull language straight from their website, sales decks, and published claims.

Primary marketing message / tagline
The one line they lead with in a pitch or on their homepage.
Top 3 clinical or performance claims
The specific claims they make publicly — numbers, comparisons, outcomes.
Where these claims are published
Peer-reviewed journal, white paper, conference poster, or sales collateral only? The venue tells you how rigorously the claim was tested.
Section D — Where Claims Might Outrun the Reality

Go looking for the gap. Forums, app store reviews, conference hallway conversations, peer-reviewed rebuttals, FDA MAUDE reports, and user complaints all live here.

What would a skeptical clinician ask?
If you handed their claims to a sharp, unaligned clinician, what's the first question they'd push back with?
Documented complaints or limitations
What shows up in reviews, forums, MAUDE/adverse-event databases, or published critiques?
Recalls, retractions, or public incidents
Anything on the regulatory or public record worth knowing about.
Section E — The Uncomfortable Questions

Answer these with someone outside the building. Resist the instinct to talk yourself out of the hard answers.

If a hospital's current process works “well enough” with this competitor, why would they tear it out for us?

What do they have — capital, relationships, data, regulatory history, install base — that we cannot realistically replicate in the next 24 months?

If we only match them feature-for-feature, why would anyone actually switch?

What is the one thing this competitor cannot or will not do — because of their size, business model, or incentives — that we could?

Where are they clearly, honestly better than us today? Write it down. Don't rationalize it away.

Section F — Implication for Our Specialization

Given everything above, what narrow wedge or use case could we own that this competitor is structurally unlikely to defend?

Our specialization opportunity against this competitor
Be specific: a use case, a patient population, a workflow moment, a buyer type — not “we'll be more innovative.”
COMPETITOR 03
Section A — The Facts

Snapshot data — pull this from public filings, FDA/CE databases, their site, LinkedIn, and press coverage.

Founded / HQ
Funding raised or parent company
Estimated revenue or market share
Install base / number of customers
Regulatory status (FDA clearance, CE mark, class, date)
Key leadership or scientific advisory board
Section B — What They're Actually Good At

Set marketing language aside for now — this is your honest technical and commercial read of their real strengths.

Core technical or clinical strength
What do they genuinely do better than most of the category — not what they say, what's actually true?
Clinical evidence strength
What published trials, studies, or real-world data actually back their product?
Distribution & channel strength
Sales force size, GPO contracts, distributor relationships, existing hospital footprint.
Brand & relationship equity
Key opinion leaders, society endorsements, conference presence, word-of-mouth trust.
Section C — What They Claim (Marketing & Clinical)

This is their voice, not yours — pull language straight from their website, sales decks, and published claims.

Primary marketing message / tagline
The one line they lead with in a pitch or on their homepage.
Top 3 clinical or performance claims
The specific claims they make publicly — numbers, comparisons, outcomes.
Where these claims are published
Peer-reviewed journal, white paper, conference poster, or sales collateral only? The venue tells you how rigorously the claim was tested.
Section D — Where Claims Might Outrun the Reality

Go looking for the gap. Forums, app store reviews, conference hallway conversations, peer-reviewed rebuttals, FDA MAUDE reports, and user complaints all live here.

What would a skeptical clinician ask?
If you handed their claims to a sharp, unaligned clinician, what's the first question they'd push back with?
Documented complaints or limitations
What shows up in reviews, forums, MAUDE/adverse-event databases, or published critiques?
Recalls, retractions, or public incidents
Anything on the regulatory or public record worth knowing about.
Section E — The Uncomfortable Questions

Answer these with someone outside the building. Resist the instinct to talk yourself out of the hard answers.

If a hospital's current process works “well enough” with this competitor, why would they tear it out for us?

What do they have — capital, relationships, data, regulatory history, install base — that we cannot realistically replicate in the next 24 months?

If we only match them feature-for-feature, why would anyone actually switch?

What is the one thing this competitor cannot or will not do — because of their size, business model, or incentives — that we could?

Where are they clearly, honestly better than us today? Write it down. Don't rationalize it away.

Section F — Implication for Our Specialization

Given everything above, what narrow wedge or use case could we own that this competitor is structurally unlikely to defend?

Our specialization opportunity against this competitor
Be specific: a use case, a patient population, a workflow moment, a buyer type — not “we'll be more innovative.”
Across all three

The synthesis

Pull the key findings from each teardown into one view. The pattern across all three tells you more than any single competitor does.

CompetitorTheir moatTheir blind spotOur wedge
Competitor 01
Competitor 02
Competitor 03

What this tells us

What strength do all three share?
That's not a differentiator — it's the price of entry to this category. You need it just to be taken seriously.
What weakness or blind spot do all three share?
That's structural, not accidental — probably a byproduct of their size, business model, or incumbency. That's your opening.
Before you move forward

The final gut check

Three questions. Answer them honestly before you finalize a go-to-market plan.

Are we trying to be a smaller version of them — or something genuinely different?

If we launched tomorrow, what's the honest reason a customer would choose us over any of these three?

What would have to be true — about our product, our evidence, our team, or our timing — for us to actually win real share within three years?